Cyclosporine promotes glomerular endothelin binding in Vivo

Midori Awazu, Masanori Sugiura, Tadashi Inagami, Lekuni Ichikawa, Valentina Kon

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

It has previously been shown that administration of cyclosporine causes a prompt (within 15 min after infusion) increase in circulating level of endothelin 1 and a pattern of glomerular hypoperfusion and hypofiltration which can be ameliorated with antiendothelin antibody. We now show that 60 min after cyclosporine, serum endothelin 1 level falls to <2.55 ± 0.31 pg/mL (N = 6), a value comparable to that found in normal animals (<2 pg/mL). The study presented here also examines whether sustained cyclosporine-induced glomerular dysfunction is associated with altered endothelin receptor characteristics. Saturation and competitive inhibition binding studies in isolated glomerular membranes showed two binding sites. Of these, the density of the low-affinity site was affected by cyclosporine treatment (851 ± 117 versus 425 ± 61 fmol/mg of protein; P< 0.05; N= 6) without a change in equilibrium dissociation constant, KD. The high-affinity site was not affected. The receptor characteristics of another vasoconstrictor, angiotensin II, were not affected by cyclosporine. In addition, there was no difference in endothelin binding sites in hepatic tissue between cyclosporine and control rats. These results raise the intriguing possibility that cyclosporine-induced glomerular dysfunction involves upregulation of endothelin binding sites and that altered endothelin receptors appear specific to the kidney.

Original languageEnglish
Pages (from-to)1253-1258
Number of pages6
JournalJournal of the American Society of Nephrology
Volume1
Issue number11
Publication statusPublished - 1991
Externally publishedYes

Fingerprint

Endothelins
Cyclosporine
Endothelin Receptors
Binding Sites
Endothelin-1
Competitive Binding
Vasoconstrictor Agents
Angiotensin II
Up-Regulation
Kidney
Membranes
Antibodies
Liver
Serum
Proteins

Keywords

  • Angiotensin
  • Cyclosporine
  • Endothelin receptor
  • Kidney

ASJC Scopus subject areas

  • Nephrology

Cite this

Awazu, M., Sugiura, M., Inagami, T., Ichikawa, L., & Kon, V. (1991). Cyclosporine promotes glomerular endothelin binding in Vivo. Journal of the American Society of Nephrology, 1(11), 1253-1258.

Cyclosporine promotes glomerular endothelin binding in Vivo. / Awazu, Midori; Sugiura, Masanori; Inagami, Tadashi; Ichikawa, Lekuni; Kon, Valentina.

In: Journal of the American Society of Nephrology, Vol. 1, No. 11, 1991, p. 1253-1258.

Research output: Contribution to journalArticle

Awazu, M, Sugiura, M, Inagami, T, Ichikawa, L & Kon, V 1991, 'Cyclosporine promotes glomerular endothelin binding in Vivo', Journal of the American Society of Nephrology, vol. 1, no. 11, pp. 1253-1258.
Awazu M, Sugiura M, Inagami T, Ichikawa L, Kon V. Cyclosporine promotes glomerular endothelin binding in Vivo. Journal of the American Society of Nephrology. 1991;1(11):1253-1258.
Awazu, Midori ; Sugiura, Masanori ; Inagami, Tadashi ; Ichikawa, Lekuni ; Kon, Valentina. / Cyclosporine promotes glomerular endothelin binding in Vivo. In: Journal of the American Society of Nephrology. 1991 ; Vol. 1, No. 11. pp. 1253-1258.
@article{23a7cade351d4395b719970abd863005,
title = "Cyclosporine promotes glomerular endothelin binding in Vivo",
abstract = "It has previously been shown that administration of cyclosporine causes a prompt (within 15 min after infusion) increase in circulating level of endothelin 1 and a pattern of glomerular hypoperfusion and hypofiltration which can be ameliorated with antiendothelin antibody. We now show that 60 min after cyclosporine, serum endothelin 1 level falls to <2.55 ± 0.31 pg/mL (N = 6), a value comparable to that found in normal animals (<2 pg/mL). The study presented here also examines whether sustained cyclosporine-induced glomerular dysfunction is associated with altered endothelin receptor characteristics. Saturation and competitive inhibition binding studies in isolated glomerular membranes showed two binding sites. Of these, the density of the low-affinity site was affected by cyclosporine treatment (851 ± 117 versus 425 ± 61 fmol/mg of protein; P< 0.05; N= 6) without a change in equilibrium dissociation constant, KD. The high-affinity site was not affected. The receptor characteristics of another vasoconstrictor, angiotensin II, were not affected by cyclosporine. In addition, there was no difference in endothelin binding sites in hepatic tissue between cyclosporine and control rats. These results raise the intriguing possibility that cyclosporine-induced glomerular dysfunction involves upregulation of endothelin binding sites and that altered endothelin receptors appear specific to the kidney.",
keywords = "Angiotensin, Cyclosporine, Endothelin receptor, Kidney",
author = "Midori Awazu and Masanori Sugiura and Tadashi Inagami and Lekuni Ichikawa and Valentina Kon",
year = "1991",
language = "English",
volume = "1",
pages = "1253--1258",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "11",

}

TY - JOUR

T1 - Cyclosporine promotes glomerular endothelin binding in Vivo

AU - Awazu, Midori

AU - Sugiura, Masanori

AU - Inagami, Tadashi

AU - Ichikawa, Lekuni

AU - Kon, Valentina

PY - 1991

Y1 - 1991

N2 - It has previously been shown that administration of cyclosporine causes a prompt (within 15 min after infusion) increase in circulating level of endothelin 1 and a pattern of glomerular hypoperfusion and hypofiltration which can be ameliorated with antiendothelin antibody. We now show that 60 min after cyclosporine, serum endothelin 1 level falls to <2.55 ± 0.31 pg/mL (N = 6), a value comparable to that found in normal animals (<2 pg/mL). The study presented here also examines whether sustained cyclosporine-induced glomerular dysfunction is associated with altered endothelin receptor characteristics. Saturation and competitive inhibition binding studies in isolated glomerular membranes showed two binding sites. Of these, the density of the low-affinity site was affected by cyclosporine treatment (851 ± 117 versus 425 ± 61 fmol/mg of protein; P< 0.05; N= 6) without a change in equilibrium dissociation constant, KD. The high-affinity site was not affected. The receptor characteristics of another vasoconstrictor, angiotensin II, were not affected by cyclosporine. In addition, there was no difference in endothelin binding sites in hepatic tissue between cyclosporine and control rats. These results raise the intriguing possibility that cyclosporine-induced glomerular dysfunction involves upregulation of endothelin binding sites and that altered endothelin receptors appear specific to the kidney.

AB - It has previously been shown that administration of cyclosporine causes a prompt (within 15 min after infusion) increase in circulating level of endothelin 1 and a pattern of glomerular hypoperfusion and hypofiltration which can be ameliorated with antiendothelin antibody. We now show that 60 min after cyclosporine, serum endothelin 1 level falls to <2.55 ± 0.31 pg/mL (N = 6), a value comparable to that found in normal animals (<2 pg/mL). The study presented here also examines whether sustained cyclosporine-induced glomerular dysfunction is associated with altered endothelin receptor characteristics. Saturation and competitive inhibition binding studies in isolated glomerular membranes showed two binding sites. Of these, the density of the low-affinity site was affected by cyclosporine treatment (851 ± 117 versus 425 ± 61 fmol/mg of protein; P< 0.05; N= 6) without a change in equilibrium dissociation constant, KD. The high-affinity site was not affected. The receptor characteristics of another vasoconstrictor, angiotensin II, were not affected by cyclosporine. In addition, there was no difference in endothelin binding sites in hepatic tissue between cyclosporine and control rats. These results raise the intriguing possibility that cyclosporine-induced glomerular dysfunction involves upregulation of endothelin binding sites and that altered endothelin receptors appear specific to the kidney.

KW - Angiotensin

KW - Cyclosporine

KW - Endothelin receptor

KW - Kidney

UR - http://www.scopus.com/inward/record.url?scp=0026166316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026166316&partnerID=8YFLogxK

M3 - Article

C2 - 1657241

AN - SCOPUS:0026166316

VL - 1

SP - 1253

EP - 1258

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 11

ER -